At a glance
Reference material information sheets and analysis instructions for your program.
General information
The following forms are for active Newborn Screening Quality Assurance Program participants. If you have questions or access issues with forms or reporting, please contact the program for help.
Participation request forms
To submit a new NSQAP participation request or to modify your existing participation enrollment, please visit the NSQAP Participant Portal.
Shipping guidelines for dried blood spots
Shipping Guidelines for Dried Blood Spot Specimens
Shipping schedule
Please check back for updates.
Quality control data reporting
Quality Control Assaying and Reporting Instructions
17 a-Hydroxyprogesterone + Total Galactose
(17OHP): Revvity GSP Neonatal
(TGAL): Revvity Neonatal Kit
Lots: A2305, B2305, C2305
Second-tier Congenital Adrenal Hyperplasia by LC-MS/MS
LC-MS/MS
Lots: A2311, B2311, C2311, D2311, E2311
GALT/Galactose-1-phosphate Uridyltransferase
Revvity Neonatal GALT Kit
Lots: A2303, B2303, C2303
anti-HIV Antibodies
Avioq HIV-1 Microelisa
Lots: A2307, B2307, C2307, D2307
Cystic Fibrosis (CFTR) DNA
xTAG® Cystic Fibrosis (CFTR) 60 kit v2
Lots: A2204-U2204
Immunoreactive Trypsinogen
Revvity GSP Neonatal
Lots: A2309, B2309, C2309, D2309
Lysosomal Storage Disorders
Lots: A2308, B2308, C2308, D2308
Second-tier Methylmalonic/Propionic Acidemia and Homocystinuria by LC-MS/MS
LC-MS/MS
Lots: A2314, B2314, C2314, D2314
Tandem MS 1
Derivatized – MS/MS non-kit
Lots: A2415, B2415, C2415, D2415
Tandem MS 1
Non-derivatized – MS/MS non-kit
Lots: A2415, B2415, C2415, D2415
Second-tier Maple Syrup Urine Disease and Phenylketonuria by LC-MS/MS
LC-MS/MS
Lots: A2313, B2313, C2313, D2313, E2313
Thyroxine
Revvity GSP Neonatal
Lots: A2300, B2300, C2300
Thyroid-Stimulating Hormone
Revvity GSP Neonatal
Lots: A2401, B2401, C2401
Proficiency testing data reporting
Anti-HIV-1 Antibodies in Dried Blood Spots (HIVPT)
Proficiency Testing Assay Instructions anti-Toxoplasma Antibodies (TOXOPT)
Second-tier Congenital Adrenal Hyperplasia by LC-MS/MS (CAHPT)
Cystic Fibrosis Mutation Detection (CFDNAPT)
Lysosomal Storage Disorders (LSDPT)
Sickle Cell Disease and Other Hemoglobinopathies (HbPT)